
Lucis is a preventive health company offering advanced blood diagnostics and personalized health plans through a subscription model. Users start with a simple blood test at certified partner labs, analyzing 60 to 80 key biomarkers to reveal hidden health imbalances and optimization opportunities. The platform provides personalized health scores, biological age, and actionable lifestyle, nutrition, and supplement recommendations, all tracked in a private dashboard. Lucis differentiates itself by delivering elite preventive care comparable to a €15,000 longevity clinic at a fraction of the cost, starting at €490/year. It serves over 1,000 users and partners with labs across France, the UK, and other European countries, positioning itself as an accessible, data-driven health optimization solution for individuals and startups.

Lucis is a preventive health company offering advanced blood diagnostics and personalized health plans through a subscription model. Users start with a simple blood test at certified partner labs, analyzing 60 to 80 key biomarkers to reveal hidden health imbalances and optimization opportunities. The platform provides personalized health scores, biological age, and actionable lifestyle, nutrition, and supplement recommendations, all tracked in a private dashboard. Lucis differentiates itself by delivering elite preventive care comparable to a €15,000 longevity clinic at a fraction of the cost, starting at €490/year. It serves over 1,000 users and partners with labs across France, the UK, and other European countries, positioning itself as an accessible, data-driven health optimization solution for individuals and startups.
Business model: Subscription preventive health service offering biomarker testing and personalized plans
Core product: Comprehensive blood diagnostics (60–100+ biomarkers), personalized health scores, biological age, and action plans
Geographic focus: Europe (partner labs across France, UK, Ireland, Portugal and other European countries)
Pricing: Consumer plans starting examples: €190/year (Discovery) and €490/year (Care)
Team size: Approximately 10 employees
Preventive health, biomarker testing, and personalized health optimization
Preventive health / Digital health / Longevity
Crunchbase lists one Seed round; amount and date not disclosed. Investors listed include Y Combinator and Rebel Fund.
“Y Combinator; Rebel Fund”